ANI Pharmaceuticals, Inc.
US ˙ NasdaqGM ˙ US00182C1036

SecurityANIP / ANI Pharmaceuticals, Inc.
InstitutionMan Group plc
Latest Disclosed Ownership208,694 shares
Latest Disclosed Value $ 16,048,569
Man Group plc reports 158.50% increase in ownership of ANIP / ANI Pharmaceuticals, Inc.

On May 15, 2026 - Man Group plc filed a 13F-HR form disclosing ownership of 208,694 shares of ANI Pharmaceuticals, Inc. (US:ANIP) valued at $16,048,569 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 80,733 shares of ANI Pharmaceuticals, Inc.. This represents a change in shares of 158.50% during the quarter. The current value of the position is $15,700,050 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ANI PHARMACEUTICALS COM 00182C103 208,694 127,961 158.50 16,049 151.81 0.0179
2026-02-17 2025-12-31 13F ANI PHARMACEUTICALS COM 00182C103 80,733 45,944 132.06 6,373 100.03 0.0108
2025-11-14 2025-09-30 13F ANI PHARMACEUTICALS COM 00182C103 34,789 2,034 6.21 3,187 49.09 0.0055
2025-08-14 2025-06-30 13F ANI PHARMACEUTICALS COM 00182C103 32,755 32,755 2,137 0.0041
2025-02-14 2024-12-31 13F ANI PHARMACEUTICALS COM 00182C103 0 -14,175 -100.00 0 -100.00
2024-11-14 2024-09-30 13F ANI PHARMACEUTICALS COM 00182C103 14,175 7,855 124.29 846 110.20 0.0022
2024-08-14 2024-06-30 13F ANI PHARMACEUTICALS COM 00182C103 6,320 -1,087 -14.68 402 -21.48 0.0010
2024-05-15 2024-03-31 13F ANI PHARMACEUTICALS COM 00182C103 7,407 2,315 45.46 512 82.86 0.0013
2024-02-14 2023-12-31 13F ANI PHARMACEUTICALS COM 00182C103 5,092 5,092 281 0.0008
2021-05-17 2021-03-31 13F ANI PHARMACEUTICALS COM 00182C103 0 -71,090 -100.00 0 -100.00
2021-02-16 2020-12-31 13F ANI PHARMACEUTICALS COM 00182C103 71,090 -11,600 -14.03 2,064 -11.53 0.0091
2020-11-16 2020-09-30 13F ANI PHARMACEUTICALS COM 00182C103 82,690 21,886 35.99 2,333 18.67 0.0092
2020-08-14 2020-06-30 13F ANI PHARMACEUTICALS COM 00182C103 60,804 -9,278 -13.24 1,966 -31.14 0.0099
2020-05-15 2020-03-31 13F ANI PHARMACEUTICALS COM 00182C103 70,082 -43,012 -38.03 2,855 -59.07 0.0185
2020-02-18 2019-12-31 13F ANI PHARMACEUTICALS COM 00182C103 113,094 28,100 33.06 6,975 12.61 0.0229
2019-11-14 2019-09-30 13F ANI PHARMACEUTICALS COM 00182C103 84,994 84,994 6,194 0.0230
2019-02-14 2018-12-31 13F ANI PHARMACEUTICALS COM 00182C103 0 -8,338 -100.00 0 -100.00
2018-11-14 2018-09-30 13F ANI PHARMACEUTICALS COM 00182C103 8,338 5,306 175.00 471 132.02 0.0017
2018-08-14 2018-06-30 13F ANI PHARMACEUTICALS COM 00182C103 3,032 3,032 203 0.0008
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.